Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

<p>Abstract</p> <p>Background</p> <p>Dual antiplatelet therapy using acetylsalicylic acid (ASA, aspirin) and clopidogrel is of great importance following coronary stenting. However, the variable platelet inhibitory effectiveness compromises the antithrombotic advantages...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Pepinghege Fenena, Lask Sebastian, Engelhardt Andreas, Krüger Jan C, Endres Heinz G, Kaiser Andreas FC, Neubauer Horst, Kusber Andreas, Mügge Andreas
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: BMC 2011-01-01
Σειρά:BMC Medicine
Διαθέσιμο Online:http://www.biomedcentral.com/1741-7015/9/3

Διαδίκτυο

http://www.biomedcentral.com/1741-7015/9/3

Παρόμοια τεκμήρια